Good Shepherd Penn Partners (GSPP) Penn Therapy and Fitness and researchers at the University of Pennsylvania have created a new program for breast cancer survivors. This new program educates survivors about lymphedema and helps them to build strength. We are pleased that this program is now available to all breast cancer survivors who have completed their cancer treatments. Ask your oncology clinician and physical therapist if you are eligible.
GSPP Penn Therapy and Fitness and Researchers at the University of Pennsylvania have teamed up to bring exercise to breast cancer survivors. Over the past few years, clinical researchers published the results of the PAL Trial. These studies showed that supervised, slowly progressive strength training can be safe and effective for breast cancer survivors.
Exercise can help you regain strength after your cancer treatment. We are here to help you return to yourself.
To speak directly with a therapist about the program, please call 215-662-4793.
Please call 877-9MYREHAB to find a location nearest you that offers this program, then make an appointment. For a complete list of locations and directions, visit www.phillyrehab.com. A physician prescription is required for our services. You may obtain a prescription from your primary care doctor or your specialty care physician.
Most major insurance plans are accepted, but insurance coverage varies from plan to plan. Please check your policy for information on referrals and coverage of services.
For More Information about Good Shepherd Penn Partners, please call toll-free 1-877-MYREHAB or visit www.phillyrehab.com.
The Physical Therapists at Good Shepherd Penn Partners and the PAL researchers have created a physical therapy program based on the results from the PAL trial.
Women who participated in the PAL study found the following benefits:
For more information, visit PennCancer.org/PAL.
Nicholas Martell was first diagnosed with prostate cancer more than ten years ago. He was healthy for many years after being treated with radiation therapy. Nick recently experienced a recurrence of his cancer. Physicians at Penn tailored his treatment and enrolled him in a new Phase I clinical trial using laser-based photodynamic therapy (PDT) followed by hormone therapy. This leading edge treatment plan was effective. Nick just returned from a vacation with his daughter, and in his free time, he plays golf every chance he gets.
Peter O'Dwyer, MD, professor of Hematology-Oncology and program director of Development Therapeutics in the Abramson Cancer Center, was interviewed on NBC10's 10! Show about Penn's work as part of the Stand Up to Cancer Dream Team... Read more